AU2008248168B2 - Processes for preparing (R)-2-methylpyrrolidine and (S)-2-methylpyrrolidine and tartrate salts thereof - Google Patents

Processes for preparing (R)-2-methylpyrrolidine and (S)-2-methylpyrrolidine and tartrate salts thereof Download PDF

Info

Publication number
AU2008248168B2
AU2008248168B2 AU2008248168A AU2008248168A AU2008248168B2 AU 2008248168 B2 AU2008248168 B2 AU 2008248168B2 AU 2008248168 A AU2008248168 A AU 2008248168A AU 2008248168 A AU2008248168 A AU 2008248168A AU 2008248168 B2 AU2008248168 B2 AU 2008248168B2
Authority
AU
Australia
Prior art keywords
methylpyrrolidine
methyl
tartrate
phenyl
pyrrolidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2008248168A
Other languages
English (en)
Other versions
AU2008248168A1 (en
Inventor
Michael Christie
Joseph J. Petraitis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon LLC
Original Assignee
Cephalon LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon LLC filed Critical Cephalon LLC
Publication of AU2008248168A1 publication Critical patent/AU2008248168A1/en
Application granted granted Critical
Publication of AU2008248168B2 publication Critical patent/AU2008248168B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Catalysts (AREA)
AU2008248168A 2007-05-03 2008-05-02 Processes for preparing (R)-2-methylpyrrolidine and (S)-2-methylpyrrolidine and tartrate salts thereof Ceased AU2008248168B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92735607P 2007-05-03 2007-05-03
US60/927,356 2007-05-03
PCT/US2008/005702 WO2008137087A1 (en) 2007-05-03 2008-05-02 Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof

Publications (2)

Publication Number Publication Date
AU2008248168A1 AU2008248168A1 (en) 2008-11-13
AU2008248168B2 true AU2008248168B2 (en) 2013-03-21

Family

ID=39688886

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008248168A Ceased AU2008248168B2 (en) 2007-05-03 2008-05-02 Processes for preparing (R)-2-methylpyrrolidine and (S)-2-methylpyrrolidine and tartrate salts thereof

Country Status (14)

Country Link
EP (1) EP2152669A1 (https=)
JP (1) JP5698887B2 (https=)
KR (1) KR20100017565A (https=)
CN (1) CN101679237A (https=)
AU (1) AU2008248168B2 (https=)
BR (1) BRPI0810330A2 (https=)
CA (1) CA2686033A1 (https=)
EA (1) EA019031B1 (https=)
IL (1) IL201627A (https=)
MX (1) MX2009011787A (https=)
NZ (1) NZ580948A (https=)
UA (1) UA99913C2 (https=)
WO (1) WO2008137087A1 (https=)
ZA (1) ZA200907643B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20130044T1 (hr) 2006-07-25 2013-02-28 Cephalon, Inc. Derivati piridizinona
US8383657B2 (en) 2007-12-21 2013-02-26 Abbott Laboratories Thiazolylidine urea and amide derivatives and methods of use thereof
EP2752406A1 (en) 2008-01-30 2014-07-09 Cephalon, Inc. Substituted pyridazine derivatives which have histamine H3 antagonist activity
MX2017008430A (es) * 2014-12-23 2018-03-23 Cephalon Inc Métodos para preparar derivados de 2,4-diaminopirimidina bíclica fusionada.
BR112021003440A2 (pt) * 2018-09-07 2021-05-18 Sanofi sais de 6-(2,4-diclorofenil)-5-[4-[(3s)-1-(3-fluoropropil) pirrolidin-3-il]oxifenil]-8,9-di-hidro-7h-benzo[7]anuleno-2-carboxilato de metila e seu processo de preparação

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3329974A1 (de) 1983-08-19 1985-02-28 Bayer Ag, 5090 Leverkusen Herstellung von hydrierten nitrilkautschuken
DE3433392A1 (de) 1984-09-12 1986-03-20 Bayer Ag, 5090 Leverkusen Hydrierung nitrilgruppenhaltiger ungesaettigter polymerer
FR2714849B1 (fr) 1994-01-13 1996-04-05 Inst Francais Du Petrole Procédé de préparation d'un catalyseur d'hydrogénation soluble en phase liquide organique.
DE4403479A1 (de) 1994-02-04 1995-08-10 Basf Ag Verfahren zur Herstellung von Hydroxylammoniumsalzen
WO2004024707A2 (en) * 2002-09-16 2004-03-25 Abbott Laboratories Process for preparing amine type substituted benzofurans
US7153889B2 (en) 2002-11-12 2006-12-26 Abbott Laboratories Bicyclic-substituted amines as histamine-3 receptor ligands
CN100543050C (zh) 2004-03-08 2009-09-23 独立行政法人科学技术振兴机构 高分子担载金属簇组合物
US7145005B2 (en) 2004-05-12 2006-12-05 Abbott Laboratories 2-(6-{2-[(2R)-2-Methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one salts and their preparation
DE602005004404T2 (de) 2004-06-02 2009-01-15 F. Hoffmann-La Roche Ag Als histamin-3-rezeptorliganden einsetzbare naphthalene-derivate
CA2588867A1 (en) 2004-12-01 2006-06-08 Banyu Pharmaceutical Co., Ltd. Substituted pyridone derivative
AU2005316337A1 (en) 2004-12-17 2006-06-22 Janssen Pharmaceutica, N.V. Tetrahydroisoquinoline compounds for treatment of CNS disorders
EP1848696A1 (en) 2005-01-21 2007-10-31 Schering Corporation Imidazole and benzimidazole derivates useful as histamine h3 antagonists
CA2602336A1 (en) 2005-03-31 2006-10-05 Ucb Pharma S.A. Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses
GB0514812D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
CA2627234A1 (en) 2005-10-27 2007-05-03 Ucb Pharma, S.A. Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
ATE525072T1 (de) 2006-02-09 2011-10-15 Athersys Inc Pyrazole zur behandlung von adipositas und anderen zns-erkrankungen
WO2007099423A1 (en) 2006-03-02 2007-09-07 Pfizer Products Inc. 1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
CA2643055A1 (en) 2006-03-13 2007-09-20 Pfizer Products Inc. Tetralines antagonists of the h-3 receptor
WO2008005338A1 (en) 2006-06-29 2008-01-10 Arena Pharmaceuticals, Inc. Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
HRP20130044T1 (hr) * 2006-07-25 2013-02-28 Cephalon, Inc. Derivati piridizinona

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SAKURAI, R. et al., Crystal Growth and Design, 2006, vol 6, pages 1606-1610 *

Also Published As

Publication number Publication date
UA99913C2 (ru) 2012-10-25
AU2008248168A1 (en) 2008-11-13
JP5698887B2 (ja) 2015-04-08
CN101679237A (zh) 2010-03-24
MX2009011787A (es) 2009-11-13
WO2008137087A1 (en) 2008-11-13
BRPI0810330A2 (pt) 2014-10-14
JP2010526142A (ja) 2010-07-29
IL201627A0 (en) 2010-05-31
CA2686033A1 (en) 2008-11-13
IL201627A (en) 2014-06-30
ZA200907643B (en) 2014-03-26
NZ580948A (en) 2011-04-29
KR20100017565A (ko) 2010-02-16
EA019031B1 (ru) 2013-12-30
EP2152669A1 (en) 2010-02-17
EA200971019A1 (ru) 2010-04-30

Similar Documents

Publication Publication Date Title
US20100121055A1 (en) Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof
JP6491393B2 (ja) ヒストン脱アセチル化酵素6阻害剤としての1,3,4−オキサジアゾール誘導体化合物及びこれを含有する薬剤学的組成物
Lourdusamy et al. Stereoselective synthesis of α-diazo oxime ethers and their application in the synthesis of highly substituted pyrroles through a [3+ 2] cycloaddition
AU2008248168B2 (en) Processes for preparing (R)-2-methylpyrrolidine and (S)-2-methylpyrrolidine and tartrate salts thereof
CN111770918B (zh) Trpc6的抑制剂
AU2021308344B2 (en) Novel compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the same
TW200403237A (en) New pyrrolidinium derivatives
JP2016524597A (ja) 選択的ヒストン脱アセチル化酵素抑制剤としての新規化合物およびこれを含む薬剤学的組成物
JP3328936B2 (ja) 5ht1dレセプター拮抗薬用インドールおよびインドリン誘導体
AU2008223145A1 (en) Tetrahydroisoquinoline compounds as modulators of the histamine H3 receptor
KR20230158007A (ko) 항바이러스 화합물
KR101685639B1 (ko) 신규한 인돌 유도체 화합물 및 이를 포함하는 약제학적 조성물
CA2791431A1 (en) Derivatives of aminoindanes, their preparation and their application in therapeutics
WO2010059393A1 (en) Serotonin receptor modulators
CN114728177A (zh) 作为Kv1.3钾Shaker通道阻滞剂的芳基杂二环化合物
JP6498672B2 (ja) 疼痛に対して多重モードの活性を有するピペリジン化合物
ES2561834T3 (es) Naftiridonas y quinolonas 7-amino alquilidenil-heterocíclicas
JP2010526142A5 (https=)
ZA200700950B (en) Pyrrole derivatives, their preparation and their therapeutic use
WO2006082872A1 (ja) 1-(ピペリジン-4-イル)-1h-インドール誘導体
KR20230164136A (ko) Kv1.3 칼륨 셰이커 채널 차단제로서의 아릴 헤테로시클릭 화합물
AU2005252178A1 (en) Histamine H3 receptor agents, preparation and therapeutic uses
JP7672386B2 (ja) オレキシン受容体調節薬としての(2h-1,2,3-トリアゾール-2-イル)フェニル化合物の改善された合成方法
WO2002089803A1 (fr) Composition d'ionophorese
Yoon‐Miller et al. Suzuki–Miyaura arylations of tetramic acid sulfonates: Evaluation of lactam protection, sulfonate esters, and sterics

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired